featured
Surgery With vs Without Chemoradiotherapy for Esophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant Chemoradiotherapy Plus Surgery Versus Surgery Alone for Oesophageal or Junctional Cancer (CROSS): Long-Term Results of a Randomised Controlled Trial
Lancet Oncol 2015 Aug 05;[EPub Ahead of Print], J Shapiro, JJ van Lanschot, MC Hulshof, P van Hagen, MI van Berge Henegouwen, BP Wijnhoven, HW van Laarhoven, GA Nieuwenhuijzen, GA Hospers, JJ Bonenkamp, MA Cuesta, RJ Blaisse, OR Busch, FJ Ten Kate, GM Creemers, CJ Punt, JT Plukker, HM Verheul, EJ Bilgen, H van Dekken, MJ van der Sangen, T Rozema, K Biermann, JC Beukema, AH Piet, CM van Rij, JG Reinders, HW Tilanus, EW Steyerberg, A van der GaastFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.